Spruce Biosciences, Inc.
SPRB
$89.20
$6.097.33%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -297.29% | 85.28% | 40.40% | -171.70% | 5.55% |
| Total Depreciation and Amortization | -57.14% | 16.67% | -33.33% | -10.00% | -16.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 223.94% | -204.66% | -56.00% | -14.73% | -31.24% |
| Change in Net Operating Assets | 136.66% | -834.66% | -53.63% | 204.76% | 52.13% |
| Cash from Operations | 39.78% | 30.64% | 38.45% | -124.19% | 16.95% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.25% | -0.25% | 0.25% | -0.25% | 0.25% |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 200.00% | -- | -- | -- |
| Cash from Financing | -0.50% | 2.68% | 34.24% | -54.32% | -10.96% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 38.04% | 29.76% | 38.33% | -121.25% | 16.07% |